Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 11,187Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Paxlovid

PharmaCompass

01

Brand Name : Paxlovid

Nirmatrelvir

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Paxlovid

arrow
2024 ACI Convention
Not Confirmed

Nirmatrelvir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 76

2020 Revenue in Millions : 0

Growth (%) : New Launch in 2021

blank

02

Brand Name : Paxlovid

Nirmatrelvir

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Paxlovid

arrow
2024 ACI Convention
Not Confirmed

Nirmatrelvir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 18,933

2021 Revenue in Millions : 76

Growth (%) : 24,812

blank

03

Brand Name : Paxlovid

Nirmatrelvir

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Paxlovid

arrow
2024 ACI Convention
Not Confirmed

Nirmatrelvir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2023 Revenue in Millions : 1,279

2022 Revenue in Millions : 18,933

Growth (%) : -93

blank